Skip to main content
Telix Pharmaceuticals Limited (TLPPF)
OTCMKTS · Delayed Price · Currency is USD
18.90
+1.40 (8.00%)
Feb 21, 2025, 3:00 PM EST

Telix Pharmaceuticals Revenue

In the year 2024, Telix Pharmaceuticals had annual revenue of 783.21M AUD with 55.85% growth. Telix Pharmaceuticals had revenue of 209.62M in the quarter ending December 31, 2024, with 48.82% growth.

Revenue
783.21M AUD
Revenue Growth
+55.85%
P/S Ratio
n/a
Revenue / Employee
3.35M AUD
Employees
234
Market Cap
6.33B USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024783.21M280.66M55.85%
Dec 31, 2023502.55M342.45M213.90%
Dec 31, 2022160.10M152.50M2,007.64%
Dec 31, 20217.60M2.38M45.71%
Dec 31, 20205.21M1.73M49.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.79B
SS Innovations International 16.04M
Veradigm 1.53B
Elite Pharmaceuticals 70.00M
Glass House Brands 188.29M
Northwest Biotherapeutics 1.60M
Silence Therapeutics 21.77M
SANUWAVE Health 29.30M
Revenue Rankings

Telix Pharmaceuticals News

More News